Company: SYRA
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001493152-25-022023
Chunk: 80

Company: Syra Health Corp
Filing Date: 2025-11-12
Form: 10-Q
Item: Item 8
Chunk 80
---
 reported, within the time periods specified in the
SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to
ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is accumulated and
communicated to a company’s management, including its principal executive officer and principal financial officer, as
appropriate to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and
procedures, management recognizes that any controls and procedures, no matter how well designed and operated, cannot provide
absolute assurance that the objectives of the controls system are met, and no evaluation of controls can provide absolute assurance
that all control issues and instances of fraud, if any, within a company have been detected. Based on the evaluation of our
disclosure controls and procedures as of September 30, 2025, our Chief Executive Officer and our Chief Financial Officer concluded
that, as of such date, our disclosure controls and procedures were effective. Effective internal control contemplates an appropriate
level of review to ensure timely preparation and completeness and accuracy of the financial statements and disclosures.

Changes
in Internal Control

There
were no changes in our internal control over financial
reporting that occurred during the three months ended September 30, 2025 that have materially affected, or are reasonably likely to materially
affect, our internal control over financial reporting.

11

PART
II — OTHER INFORMATION

ITEM
1. LEGAL PROCEEDINGS.

From
time to time, we may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation
is subject to inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business.
We are currently not aware of any such legal proceedings or claims that will have, individually or in the aggregate, a material adverse
effect on our business, financial condition or operating results.

ITEM
1A. RISK FACTORS.

In
addition to other information set forth in this report, readers should carefully consider the risk factors discussed in the Company’s
Annual Report on Form 10-K for the year ended December 31, 2024. Any of the risk factors disclosed in the Annual Report or our reports
could materially affect our business, financial condition or future results. The risks described in the Prospectus are not the only risks
we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial